Rancho Santa Fe, CA, United States of America

Sheila Gujrathi

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Sheila Gujrathi: Innovator in Therapeutic Antibodies

Introduction

Sheila Gujrathi is a prominent inventor based in Rancho Santa Fe, CA (US). She has made significant contributions to the field of medicine, particularly in the development of therapeutic antibodies. With a total of 3 patents, her work focuses on innovative methods for treating diseases where interleukin-13 (IL-13) activity is detrimental.

Latest Patents

One of her latest patents involves methods of treatment for diseases in which IL-13 activity is harmful. This includes conditions such as eosinophilic esophagitis (EoE) and asthma. The invention describes administering a composition containing an IL-13 antibody or an antigen-binding fragment to patients in need of such treatment. This innovative approach aims to provide effective solutions for managing these challenging health issues.

Career Highlights

Throughout her career, Sheila has worked with notable companies, including AbbVie Inc. and AbbVie Manufacturing Management Unlimited Company. Her experience in these organizations has allowed her to develop and refine her expertise in therapeutic innovations.

Collaborations

Sheila has collaborated with esteemed colleagues such as Gregg Timony and Robert Peach. These partnerships have contributed to her success and the advancement of her research in the field of therapeutic antibodies.

Conclusion

Sheila Gujrathi's work exemplifies the impact of innovative thinking in medicine. Her patents and collaborations highlight her commitment to improving treatment options for patients suffering from diseases linked to IL-13 activity.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…